BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2232257)

  • 21. Rapid amidolytic assay of protein C in whole plasma using an activator from the venom of Agkistrodon contortrix.
    Francis RB; Seyfert U
    Am J Clin Pathol; 1987 May; 87(5):619-25. PubMed ID: 3578135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a protein C activator from the venom of Agkistrodon contortrix contortrix.
    Orthner CL; Bhattacharya P; Strickland DK
    Biochemistry; 1988 Apr; 27(7):2558-64. PubMed ID: 3382639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fast functional assay of protein C in whole plasma using a snake venom activator: evaluation in patients with congenital and acquired protein C deficiencies.
    Takahashi H; Hanano M; Tatewaki W; Shibata A
    Clin Chim Acta; 1988 Jul; 175(3):217-25. PubMed ID: 3416483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the protein C activator Protac from the venom of the southern copperhead (Agkistrodon contortrix) snake.
    Stocker K; Fischer H; Meier J; Brogli M; Svendsen L
    Toxicon; 1987; 25(3):239-52. PubMed ID: 3590209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor VIII: C (FVIII: C) recovery and half-life after infusion of steam-treated high purity factor VIII concentrate in severe hemophilia A--comparison of one-stage assay, two-stage assay and a chromogenic substrate assay.
    Hellstern P; Kiehl R; Miyashita C; Schwerdt H; von Blohn G; Köhler M; Büttner M; Wenzel E
    Thromb Haemost; 1986 Dec; 56(3):353-9. PubMed ID: 3105109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical application of a functional assay for protein C.
    Triplett DA; Sandquist DS; Musgrave KA
    Hematol Pathol; 1987; 1(4):239-47. PubMed ID: 3143709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Simultaneous determination of zymogen activation time and zymogen level using chromogenic substrates in blood coagulation analysis].
    Svendsen L; Brogli M; Stocker K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):150-6. PubMed ID: 6177596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of Protein C activator from
    Sun Y; Bao PJ; Zhang GB
    Prep Biochem Biotechnol; 2020; 50(9):907-914. PubMed ID: 32478599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venom Protein C Activators as Diagnostic Agents for Defects of Protein C System.
    Asmat A; Ramzan F
    Protein Pept Lett; 2018; 25(7):643-651. PubMed ID: 29921197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contact factor proteases and the complexes formed with alpha 2-macroglobulin can interfere in protein C assays by cleaving amidolytic substrates.
    Mackie IJ; Gallimore M; Machin SJ
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):589-95. PubMed ID: 1280470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of a fibrinolytic enzyme from the larvae of Lonomia achelous (Cramer) using chromogenic peptide substrates.
    Arocha-Piñango CL; Pepper DS
    Thromb Haemost; 1981 Dec; 46(4):710-3. PubMed ID: 7330821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.
    Vigano D'Angelo S; Comp PC; Esmon CT; D'Angelo A
    J Clin Invest; 1986 Feb; 77(2):416-25. PubMed ID: 3511097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S.
    van Wijnen M; van 't Veer C; Meijers JC; Bertina RM; Bouma BN
    Thromb Haemost; 1998 Dec; 80(6):930-5. PubMed ID: 9869163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Pro-C global for identification of defects in protein C/S anticoagulant pathway.
    Bin Hanif T; Anwar J; Idrees M
    J Ayub Med Coll Abbottabad; 2011; 23(1):89-91. PubMed ID: 22830156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein C activators from snake venoms and their diagnostic use.
    Gempeler-Messina PM; Volz K; Bühler B; Müller C
    Haemostasis; 2001; 31(3-6):266-72. PubMed ID: 11910194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein C activation by an activator purified from the venom of Agkistrodon halys halys.
    Bakker HM; Tans G; Yukelson LY; Janssen-Claessen TW; Bertina RM; Hemker HC; Rosing J
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):605-14. PubMed ID: 8218858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystallization and preliminary X-ray crystallographic studies of Protac, a commercial protein C activator isolated from Agkistrodon contortrix contortrix venom.
    Murakami MT; Arni RK
    Biochim Biophys Acta; 2005 Sep; 1752(2):202-4. PubMed ID: 16129664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cohn process influences the functional anticoagulant activity of human protein C.
    Wang ZK; Du X; Wang YM; Li CQ; Lin FZ; Cao HJ; Ye SL; Hu JJ; Yuan J
    Genet Mol Res; 2015 Feb; 14(1):860-70. PubMed ID: 25730025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302.
    Ito R; Statland BE
    Clin Chem; 1981 Apr; 27(4):586-93. PubMed ID: 6907061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.